Loading
PDBj
メニューPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

7EFR

Structure of SARS-CoV-2 spike receptor-binding domain in complex with high affinity ACE2 mutant (T27W,N330Y)

7EFR の概要
エントリーDOI10.2210/pdb7efr/pdb
分子名称Processed angiotensin-converting enzyme 2, Spike glycoprotein, 2-acetamido-2-deoxy-beta-D-glucopyranose, ... (4 entities in total)
機能のキーワードreceptor-binding domain, angiotensin converting enzyme 2, viral protein
由来する生物種Homo sapiens (Human)
詳細
タンパク質・核酸の鎖数2
化学式量合計94982.52
構造登録者
Lu, G.W.,Ye, F.,Lin, X. (登録日: 2021-03-23, 公開日: 2021-11-24, 最終更新日: 2024-10-16)
主引用文献Ye, F.,Lin, X.,Chen, Z.,Yang, F.,Lin, S.,Yang, J.,Chen, H.,Sun, H.,Wang, L.,Wen, A.,Zhang, X.,Dai, Y.,Cao, Y.,Yang, J.,Shen, G.,Yang, L.,Li, J.,Wang, Z.,Wang, W.,Wei, X.,Lu, G.
S19W, T27W, and N330Y mutations in ACE2 enhance SARS-CoV-2 S-RBD binding toward both wild-type and antibody-resistant viruses and its molecular basis.
Signal Transduct Target Ther, 6:343-343, 2021
Cited by
PubMed Abstract: SARS-CoV-2 recognizes, via its spike receptor-binding domain (S-RBD), human angiotensin-converting enzyme 2 (ACE2) to initiate infection. Ecto-domain protein of ACE2 can therefore function as a decoy. Here we show that mutations of S19W, T27W, and N330Y in ACE2 could individually enhance SARS-CoV-2 S-RBD binding. Y330 could be synergistically combined with either W19 or W27, whereas W19 and W27 are mutually unbeneficial. The structures of SARS-CoV-2 S-RBD bound to the ACE2 mutants reveal that the enhanced binding is mainly contributed by the van der Waals interactions mediated by the aromatic side-chains from W19, W27, and Y330. While Y330 and W19/W27 are distantly located and devoid of any steric interference, W19 and W27 are shown to orient their side-chains toward each other and to cause steric conflicts, explaining their incompatibility. Finally, using pseudotyped SARS-CoV-2 viruses, we demonstrate that these residue substitutions are associated with dramatically improved entry-inhibition efficacy toward both wild-type and antibody-resistant viruses. Taken together, our biochemical and structural data have delineated the basis for the elevated S-RBD binding associated with S19W, T27W, and N330Y mutations in ACE2, paving the way for potential application of these mutants in clinical treatment of COVID-19.
PubMed: 34531369
DOI: 10.1038/s41392-021-00756-4
主引用文献が同じPDBエントリー
実験手法
X-RAY DIFFRACTION (2.494 Å)
構造検証レポート
Validation report summary of 7efr
検証レポート(詳細版)ダウンロードをダウンロード

248942

件を2026-02-11に公開中

PDB statisticsPDBj update infoContact PDBjnumon